| Danielle Davis Decourcey, MD | |
|
4975 Lacross Road Suite 150, North Charleston, SC 29406-1110 | |
| (843) 737-9467 | |
| Not Available |
| Full Name | Danielle Davis Decourcey |
|---|---|
| Gender | Female |
| Speciality | Pediatrics |
| Location | 4975 Lacross Road Suite 150, North Charleston, South Carolina |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073001632 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | 308417 (New York) | Secondary |
| 208000000X | Pediatrics | 86850 (South Carolina) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Danielle Davis Decourcey, MD 4975 Lacross Road Suite 150, North Charleston, SC 29406 Ph: (843) 737-9467 | Danielle Davis Decourcey, MD 4975 Lacross Road Suite 150, North Charleston, SC 29406-1110 Ph: (843) 737-9467 |
News Archive
Giant American drug companies Merck and Bristol-Myers Squibb, have signed agreements to develop a treatment called a microbicide, a gel or a cream that women can use to protect themselves from AIDS.
SynCo Bio Partners, a Netherlands based biopharmaceutical contract manufacturer, and Versartis, Inc. today announced a strategic partnership to produce Versartis' lead drug candidate VRS-859, a novel GLP-1 analog for monthly dosing to treat type 2 diabetes Under the agreement, SynCo will further develop the Versartis existing production process for VRS-859 and optimize the manufacturing process to increase yields for the forthcoming cGMP production.
Researchers at Vanderbilt University Medical Center and colleagues have identified a gene that increases the risk for a severe and potentially life-threatening reaction to the commonly prescribed antibiotic vancomycin.
In a study that holds major implications for breast cancer research as well as basic cell biology, scientists with the U.S. Department of Energy (DOE)'s Lawrence Berkeley National Laboratory have discovered a rotational motion that plays a critical role in the ability of breast cells to form the spherical structures in the mammary gland known as acini.
Targacept, Inc., a clinical-stage biopharmaceutical company developing a new class of drugs known as NNR Therapeutics-, today announced the presentation of data from its recently completed Phase 2b clinical trial of TC-5214 as an augmentation (add-on) treatment in subjects with major depressive disorder, or MDD, who did not respond adequately to first-line treatment with the representative SSRI citalopram hydrobromide.
› Verified 6 days ago
Anna C Pruitt, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 3800 Faber Place Dr, North Charleston, SC 29405 Phone: 843-747-4647 Fax: 843-745-0969 | |
Dr. Sumita Kumari Debroy, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 2713 Dantzler Dr, North Charleston, SC 29406 Phone: 843-764-1722 Fax: 843-764-1788 | |
Dr. Jordan Stuart Whatley, M.D. Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 2250 Mall Dr, North Charleston, SC 29406 Phone: 843-876-0444 Fax: 310-206-0203 | |
Casey Harvey King, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 2713 Dantzler Dr, North Charleston, SC 29406 Phone: 843-764-1722 Fax: 843-764-1788 | |
Dr. Farrow Counts Durant, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 2713 Dantzler Dr, North Charleston, SC 29406 Phone: 843-764-1722 Fax: 843-764-1788 | |
Carol K Klauber, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 3800 Faber Place Dr, North Charleston, SC 29405 Phone: 843-747-4647 Fax: 843-745-0969 |